semaglutide nausea attorney in louisiana Ozempic semaglutide nausea lawsuit in louisiana
Description
Although quite expensive, many are willing to deal with the side effects (and there are quite a few) in exchange for the promise of weight loss
This is because semaglutide is a so-called GLP-1 receptor agonist
These dual-action effects provide a notable advantage over other medications that only target GLP-1, offering comprehensive management of weight-related health issues
At the highest dose, 96% of participants achieved at least 5% body weight reduction, and 36.2% achieved reductions of 25% or more
Ozempic should be injected subcutaneously into fatty tissue, not into a vein or muscle
Since the U.S
